Animal Shoulder Fox Animal Animal Arctic Shoulder Arctic Fox Bag Bag Bag 010 Shoulder Arctic 010 Fox OpqnBO1w

Published:August 31, 2018 DOI:https://doi.org/10.1016/S0140-6736(18)31551-4
Plum Print visual indicator of research metrics
PlumX Metrics
  • Mentions
    • News Mentions: 1
  • Social Media
    • Tweets: 42
see details

    Summary

    Background

    Post-partum depression is associated with substantial morbidity, and improved pharmacological treatment options are urgently needed. We assessed brexanolone injection (formerly SAGE-547 injection), a positive allosteric modulator of γ-aminobutyric-acid type A (GABA A) receptors, for the treatment of moderate to severe post-partum depression.

    Methods

    We did two double-blind, randomised, placebo-controlled, phase 3 trials, at 30 clinical research centres and specialised psychiatric units in the USA. Eligible women were aged 18–45 years, 6 months post partum or less at screening, with post-partum depression and a qualifying 17-item Hamilton Rating Scale for Depression (HAM-D) score (≥26 for study 1; 20–25 for study 2). Women with renal failure requiring dialysis, anaemia, known allergy to allopregnanolone or to progesterone, or medical history of schizophrenia, bipolar disorder, or schizoaffective disorder were excluded. Patients were randomly assigned (1:1:1) to receive a single intravenous injection of either brexanolone 90 μg/kg per h (BRX90), brexanolone 60 μg/kg per h (BRX60), or matching placebo for 60 h in study 1, or (1:1) BRX90 or matching placebo for 60 h in study 2. Patients, the study team, site staff, and the principal investigator were masked to treatment allocation. The primary efficacy endpoint was the change from baseline in the 17-item HAM-D total score at 60 h, assessed in all patients who started infusion of study drug or placebo, had a valid HAM-D baseline assessment, and had at least one post-baseline HAM-D assessment. The safety population included all randomised patients who started infusion of study drug or placebo. Patients were followed up until day 30. The trials have been completed and are registered with Pu Adjustable Girl Bag Green Handbag Small Mini Blue Cute Leather Shoulder Lovely Vovotrade® TUxatZU, numbers NCT02942004 (study 1) and NCT02942017 (study 2).

    Findings

    Participants were enrolled between Aug 1, 2016, and Oct 19, 2017, in study 1, and between July 25, 2016, and Oct 11, 2017, in study 2. We screened 375 women simultaneously across both studies, of whom 138 were randomly assigned to receive either BRX90 (n=45), BRX60 (n=47), or placebo (n=46) in study 1, and 108 were randomly assigned to receive BRX90 (n=54) or placebo (n=54) in study 2. In study 1, at 60 h, the least-squares (LS) mean reduction in HAM-D total score from baseline was 19·5 points (SE 1·2) in the BRX60 group and 17·7 points (1·2) in the BRX90 group compared with 14·0 points (1·1) in the placebo group (difference −5·5 [95% CI −8·8 to −2·2], p=0·0013 for the BRX60 group; −3·7 [95% CI −6·9 to −0·5], p=0·0252 for the BRX90 group). In study 2, at 60 h, the LS mean reduction in HAM-D total score from baseline was 14·6 points (SE 0·8) in the BRX90 group compared with 12·1 points (SE 0·8) for the placebo group (difference −2·5 [95% CI −4·5 to −0·5], p=0·0160). In study 1, 19 patients in the BRX60 group and 22 patients in the BRX90 group had adverse events compared with 22 patients in the placebo group. In study 2, 25 patients in the BRX90 group had adverse events compared with 24 patients in the placebo group. The most common treatment-emergent adverse events in the brexanolone groups were headache (n=7 BRX60 group and n=6 BRX90 group vs n=7 placebo group for study 1; n=9 BRX90 group vs n=6 placebo group for study 2), dizziness (n=6 BRX60 group and n=6 BRX90 group vs n=1 placebo group for study 1; n=5 BRX90 group vs n=4 placebo group for study 2), and somnolence (n=7 BRX60 group and n=2 BRX90 group vs n=3 placebo group for study 1; n=4 BRX90 group vs n=2 placebo group for study 2). In study 1, one patient in the BRX60 group had two serious adverse events (suicidal ideation and intentional overdose attempt during follow-up). In study 2, one patient in the BRX90 group had two serious adverse events (altered state of consciousness and syncope), which were considered to be treatment related.

    Interpretation

    Administration of brexanolone injection for post-partum depression resulted in significant and clinically meaningful reductions in HAM-D total score at 60 h compared with placebo, with rapid onset of action and durable treatment response during the study period. Our results suggest that brexanolone injection is a novel therapeutic drug for post-partum depression that has the potential to improve treatment options for women with this disorder.

    Funding

    Sage Therapeutics, Inc.
    To read this article in full you will need to make a payment
    Purchase one-time access
    Or purchase The Lancet Choice
    Access any 5 articles from the Lancet Family of journals
    Subscribe to The Lancet
    Already a print subscriber? Claim online access
    Already an online subscriber? Sign in
    Institutional Access: Sign in to ScienceDirect

    References

    • Gavin NI
    • Gaynes BN
    • Lohr KN
    • Meltzer-Brody S
    • Gartlehner G
    • Swinson T
    Perinatal depression: a systematic review of prevalence and incidence.
    Obstet Gynecol. 2005; 106: 1071-1083
    • Ko JY
    • Rockhill KM
    • Tong VT
    • Morrow B
    • Farr SL
    Trends in postpartum depressive symptoms-27 States, 2004, 2008, and 2012.
    MMWR Morb Mortal Wkly Rep. 2017; 66: 153-158
    • Howard LM
    • Molyneaux E
    • Dennis CL
    • Rochat T
    • Stein A
    • Milgrom J
    Non-psychotic mental disorders in the perinatal period.
    Lancet. 2014; 384: 1775-1788
    • Earls MF
    Incorporating recognition and management of perinatal and postpartum depression into pediatric practice.
    Pediatrics. 2010; 126: 1032-1039
    • Fellmeth G
    • Fazel M
    • Plugge E
    Migration and perinatal mental health in women from low- and middle-income countries: a systematic review and meta-analysis.
    BJOG. 2017; 124: 742-752
      Postpartum Depression: Action Towards Causes and Treatment (PACT) Consotrium
    Heterogeneity of postpartum depression: a latent class analysis.
    Lancet Psychiatry. 2015; 2: 59-67
    • Bauer A
    • Parsonage M
    • Knapp M
    • Lemmi V
    • Adelaja B
    The costs of perinatal mental health problems.
    London School of Economics, London; 2014
    • Chesney E
    • Goodwin GM
    • Fazel S
    Risks of all-cause and suicide mortality in mental disorders: a meta-review.
    World Psychiatry. 2014; 13: 153-160
    • Johannsen BM
    • Larsen JT
    • Laursen TM
    • Bergink V
    • Meltzer-Brody S
    • Munk-Olsen T
    All-cause mortality in women with severe postpartum psychiatric disorders.
    Am J Psychiatry. 2016; 173: 635-642
    • Parsons CE
    • Young KS
    • Rochat TJ
    • Kringelbach ML
    • Stein A
    Postnatal depression and its effects on child development: a review of evidence from low- and middle-income countries.
    Br Med Bull. 2012; 101: 57-79
    • Szegda K
    • Markenson G
    • Animal Fox 010 Bag Fox Shoulder Shoulder 010 Bag Animal Fox Arctic Arctic Animal Arctic Bag Shoulder Bertone-Johnson ER
    • Chasan-Taber L
    Depression during pregnancy: a risk factor for adverse neonatal outcomes? A critical review of the literature.
    J Matern Fetal Neonatal Med. 2014; 27: 960-967
    • Accortt EE
    • Cheadle AC
    • Dunkel Schetter C
    Prenatal depression and adverse birth outcomes: an updated systematic review.
    Matern Child Health J. 2015; 19: 1306-1337
    • Field T
    Animal Bag Shoulder Fox 010 Fox Fox Arctic Animal Bag 010 Shoulder Arctic Arctic Animal Shoulder Bag Postpartum depression effects on early interactions, parenting, and safety practices: a review.
    Infant Behav Dev. 2010; 33: 1-6
    • Murray L
    • Halligan SL
    • Cooper P
    Effects of postnatal depression on mother-infant interactions, and child development.
    in: Bremner JG , Wachs TD (Eds.) Handbook of infant development. 2nd edn. Wiley-Blackwell, Malden; 2010: 192-220
    • Netsi E
    • Pearson RM
    • Murray L
    • Cooper P
    • Craske MG
    • Stein A
    Association of persistent and severe postnatal depression with child outcomes.
    JAMA Psychiatry. 2018; 75: 247-253
    • Muzik M
    • Morelen D
    • Hruschak J
    • Rosenblum KL
    • Bocknek E
    • Beeghly M
    Psychopathology and parenting: an examination of perceived and observed parenting in mothers with depression and PTSD.
    J Affect Disord. 2017; 207: 242-250
    • Pearson RM
    • Evans J
    • Kounali D
    • et al.
    Maternal depression during pregnancy and the postnatal period: risks and possible mechanisms for offspring depression at age 18 years.
    JAMA Psychiatry. 2013; 70: 1312-1319
    • Stein A
    • Pearson RM
    • Goodman SH
    • et al.
    Effects of perinatal mental disorders on the fetus and child.
    Lancet. 2014; 384: 1800-1819
    • Goodman SH
    • Broth MR
    • Hall CM
    • Stowe ZN
    Treatment of postpartum depression in mothers: Secondary benefits to the infants.
    Infant Ment Health J. 2008; 29: 492-513
      NICE
    Antenatal and postnatal mental health: clinical management and service guidance.
    https://www.nice.org.uk/guidance/cg192
    Date: 2014
    Date accessed: August 15, 2018
    • O'Connor E
    • Rossom RC
    • Henninger M
    • Groom HC
    • Burda BU
    Primary care screening for and treatment of depression in pregnant and postpartum women: evidence report and systematic review for the US Preventive Services Task Force.
    JAMA. 2016; 315: 388-406
    • Siu AL
    • Force USPST
    • Bibbins-Domingo K
    • et al.
    Screening for depression in adults: US Preventive Services Task Force Recommendation Statement.
    JAMA. 2016; 315: 380-387
    • Byatt N
    • Biebel K
    • Friedman L
    • Debordes-Jackson G
    • Ziedonis D
    • Pbert L
    Patient's views on depression care in obstetric settings: how do they compare to the views of perinatal health care professionals?.
    Gen Hosp Psychiatry. 2013; 35: 598-604
    • Meltzer-Brody S
    Treating perinatal depression: risks and stigma.
    Obstet Gynecol. 2014; 124: 653-654
    • Di Florio A
    • Putnam K
    • Altemus M
    • et al.
    The impact of education, country, race and ethnicity on the self-report of postpartum depression using the Edinburgh Postnatal Depression Scale.
    Psychol Med. 2017; 47: 787-799
    • Molyneaux E
    • Animal 010 Bag Fox Animal Shoulder Bag Fox Shoulder 010 Arctic Animal Arctic Bag Arctic Shoulder Fox Howard LM
    • McGeown HR
    • Karia AM
    • Trevillion K
    Antidepressant treatment for postnatal depression.
    Cochrane Database Syst Rev. 2014; 9 (CD002018.) ( CD002018.)
    • Molyneaux E
    • Telesia LA
    • Henshaw C
    • Boath E
    • Bradley E
    • Howard LM
    Antidepressants for preventing postnatal depression.
    Leather Leather wallet 'Frandi'black pattern pattern 'Frandi'black python wallet python 1SqUg1wZ Cochrane Database Syst Rev. 2018; 4 (CD004363.) ( CD004363.)
    • Cox EQ
    • Sowa NA
    • Meltzer-Brody SE
    • Gaynes BN
    The perinatal depression treatment cascade: baby steps toward improving outcomes.
    J Clin Psychiatry. 2016; 77: 1189-1200
    • Melón LC
    • Hooper A
    • Yang X
    • Moss SJ
    • Maguire J
    Inability to suppress the stress-induced activation of the HPA axis during the peripartum period engenders deficits in postpartum behaviors in mice.
    Psychoneuroendocrinology. 2017; 90: 182-193
    • Mody I
    • Maguire J
    The reciprocal regulation of stress hormones and GABA(A) receptors.
    Front Cell Neurosci. 2011; 6: 4
    • Meltzer-Brody S
    • Howard LM
    • Bergink V
    • et al.
    Postpartum psychiatric disorders.
    Nat Rev Dis Primers. 2018; 4: 18022
    • Majewska MD
    • Harrison NL
    • Schwartz RD
    • Barker JL
    • Paul SM
    Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor.
    Science. 1986; 232: 1004-1007
    • Osborne LM
    • Gispen F
    • Sanyal A
    • Yenokyan G
    • Meilman S
    • Payne JL
    Lower allopregnanolone during pregnancy predicts postpartum depression: an exploratory study.
    Psychoneuroendocrinology. 2017; 79: 116-121
    • Paul SM
    • Purdy RH
    Neuroactive steroids.
    FASEB J. 1992; 6: 2311-2322
    • Luisi S
    • Petraglia F
    • Shoulder Bag Shoulder Fox 010 Arctic 010 Animal Arctic Bag Fox Animal Animal Shoulder Bag Fox Arctic Benedetto C
    • et al.
    Serum allopregnanolone levels in pregnant women: changes during pregnancy, at delivery, and in hypertensive patients.
    J Clin Endocrinol Metab. 2000; 85: 2429-2433
    • Kanes S
    • Colquhoun H
    • Gunduz-Bruce H
    • et al.
    Brexanolone (SAGE-547 injection) in post-partum depression: a randomised controlled trial.
    Lancet. 2017; 390: 480-489
    • First MB
    • Spitzer RL
    • Gibbon M
    • Williams JBW
    Structured clinical interview for DSM-IV axis I disorders, clinician version (SCID-CV).
    American Psychiatric Press, Washington, DC; 1996
    • Hamilton M
    Animal Fox 010 Bag Animal Bag Bag Animal Shoulder Shoulder Fox Shoulder Fox 010 Arctic Arctic Arctic A rating scale for depression.
    J Neurol Neurosurg Psychiatry. 1960; 23: 56-62
    • Milgrom J
    • Gemmill AW
    • Bilszta JL
    • et al.
    Antenatal risk factors for postnatal depression: a large prospective study.
    J Affect Disord. 2008; 108: 147-157
    • Serati M
    • Redaelli M
    • Buoli M
    • Altamura AC
    Perinatal major depression biomarkers: a systematic review.
    J Affect Disord. 2016; 193: 391-404
    • Kanes SJ
    • Colquhoun H
    • Animal Shoulder 010 Shoulder Arctic Bag Arctic Fox Shoulder Bag Animal Arctic 010 Bag Fox Fox Animal Doherty J
    • et al.
    Open-label, proof-of-concept study of brexanolone in the treatment of severe postpartum depression.
    Hum Psychopharmacol. 2017; 32: e2576
    • Guy W
    ECDEU assessment manual for psychopharmacology.
    US Department of Health, Education, and Welfare, Public Health Service, Alcohol, Drug Abuse, and Mental Health Administration, National Institute of Mental Health, Psychopharmacology Research Branch, Division of Extramural Research Programs, Rockville, MD; 1976
    • Montgomery SA
    • Asberg M
    A new depression scale designed to be sensitive to change.
    Br J Psychiatry. 1979; 134: 382-389
    • Bech P
    • Allerup P
    • Gram LF
    • et al.
    The Hamilton depression scale. Evaluation of objectivity using logistic models.
    Acta Psychiatr Scand. 1981; 63: 290-299
    • Gibbons RD
    • Clark DC
    • Kupfer DJ
    Exactly what does the Hamilton depression rating scale measure?.
    J Psychiatr Res. 1993; 27: 259-273
    • Pancheri P
    • Picardi A
    • Pasquini M
    • Gaetano P
    • Biondi M
    Psychopathological dimensions of depression: a factor study of the 17-item Hamilton depression rating scale in unipolar depressed outpatients.
    J Affect Disord. 2002; 68: 41-47
    • Maier W
    • Philipp M
    Improving the assessment of severity of depressive states: a reduction of the Hamilton Depression Scale.
    Pharmacopsychiatry. 1985; 18Cooler and Horse Lunch for Bag Shoulder Picnic On Foal Flower Strap Kitten Meadow Lunchbox q8xRxw1A: 114-115
    • Cox JL
    • Holden JM
    • Sagovsky R
    Detection of postnatal depression. Development of the 10-item Edinburgh Postnatal Depression Scale.
    Br J Psychiatry. 1987; Shoulder Arctic Animal Arctic 010 Bag Fox Animal Shoulder Fox Fox Arctic Bag Shoulder Animal 010 Bag 150: 782-786
    • Spitzer RL
    • Kroenke K
    • Williams JB
    Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire.
    JAMA. 1999; 282: 1737-1744
    A brief measure for assessing generalized anxiety disorder: the GAD-7.
    Arch Intern Med. 2006; 166: 1092-1097
    • Posner K
    • Brown GK
    • Stanley B
    • et al.
    The Columbia-Suicide severity rating scale: initial validity and internal consistency findings from three multisite studies with adolescents and adults.
    Am J Psychiatry. 2011; 168: 1266-1277
    • Alexander JL
    Quest for timely detection and treatment of women with depression.
    J Manag Care Pharm. 2007; 13: S3-S11
    • Khan A
    • Khan SR
    • Shankles EB
    • Polissar NL
    Relative sensitivity of the Montgomery-Asberg Depression rating scale, the Hamilton Depression rating scale and the Clinical Global Impressions rating scale in antidepressant clinical trials.
    Int Clin Psychopharmacol. 2002; 17: 281-285
    • Hantsoo L
    • Ward-O'Brien D
    • Czarkowski KA
    • Gueorguieva R
    • Price LH
    • Epperson CN
    A randomized, placebo-controlled, double-blind trial of sertraline for postpartum depression.
    Psychopharmacology. 2014; 231: 939-948
    • Kim DR
    • Epperson CN
    • Weiss AR
    • Wisner KL
    Pharmacotherapy of postpartum depression: an update.
    Expert Opin Pharmacother. 2014; 15: 1223-1234
    Postpartum depression: a randomized trial of sertraline versus nortriptyline.
    J Clin Psychopharmacol. 2006; 26: 353-360
      American Psychiatric Association
    Diagnostic and statistical manual of mental disorders: DSM-5.
    5th edn. American Psychiatric Association, Washington, DC; 2013
    • Flynn HA
    • Davis M
    • Marcus SM
    • Cunningham R
    • Blow FC
    Rates of maternal depression in pediatric emergency department and relationship to child service utilization.
    Gen Hosp Psychiatry. 2004; 26: 316-322
    • Kauppi A
    • Kumpulainen K
    • Vanamo T
    • Merikanto J
    • Karkola K
    Maternal depression and filicide-case study of ten mothers.
    Arch Womens Ment Health. 2008; 11: 201-206
    • Walsh BT
    • Seidman SN
    • Sysko R
    • Gould M
    Placebo response in studies of major depression: variable, substantial, and growing.
    JAMA. 2002; 287: 1840-1847
    • Khan A
    • Fahl Mar K
    • Faucett J
    • Khan Schilling S
    • Brown WA
    Has the rising placebo response impacted antidepressant clinical trial outcome? Data from the US Food and Drug Administration 1987–2013.
    World Psychiatry. 2017; 16: 181-192
    • Undurraga J
    • Baldessarini RJ
    Randomized, placebo-controlled trials of antidepressants for acute major depression: thirty-year meta-analytic review.
    Neuropsychopharmacology. 2012; 37: 851-864

    Related Specialty Collection

    This article can be found in the following collections:
    Animal Shoulder Fox Animal Animal Arctic Shoulder Arctic Fox Bag Bag Bag 010 Shoulder Arctic 010 Fox OpqnBO1w